title: Expert consensus document: A consensus on the medical treatment of acromegaly.
abstract: In March 2013, the Acromegaly Consensus Group met to revise and update guidelines for the medical treatment of acromegaly. The meeting comprised experts skilled in the medical management of acromegaly. The group considered treatment goals covering biochemical, clinical and tumour volume outcomes, and the place in guidelines of somatostatin receptor ligands, growth hormone receptor antagonists and dopamine agonists, and alternative modalities for treatment including combination therapy and novel treatments. This document represents the conclusions of the workshop consensus.
authors.affiliation: Chair of Endocrinology, University of Brescia, via Biseo 17, 25100 Brescia, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Giustina
authors.affiliation: Assistance Publique-Hôpitaux de Paris, Service d'Endocrinologie et des Maladies de la Reproduction, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Paris, F 94275, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Chanson
authors.affiliation: Neuroendocrine Unit, New York University School of Medicine, Department of Veterans Affairs Medical Centre, 423 East 23rd Street, Room 16043W, New York, NY 10010, USA.
authors.forename: David
authors.initials: D
authors.lastname: Kleinberg
authors.affiliation: Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School, Avenue Dr. Eneas de Carvalho, 255, 7° Andar, Sala 7037, São Paulo, CEP 05403 000, Brazil.
authors.forename: Marcello D
authors.initials: MD
authors.lastname: Bronstein
authors.affiliation: Department of Medicine, University of North Carolina, CB# 7170, 8024 Burnett-Womack, Chapel Hill, NC 27599, USA.
authors.forename: David R
authors.initials: DR
authors.lastname: Clemmons
authors.affiliation: Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.
authors.forename: Anne
authors.initials: A
authors.lastname: Klibanski
authors.affiliation: Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Centre, P.O. Box 2040, 3000 CA Rotterdam, Netherlands.
authors.forename: Aart J
authors.initials: AJ
authors.lastname: van der Lely
authors.affiliation: Department of Endocrinology, Charite Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany.
authors.forename: Christian J
authors.initials: CJ
authors.lastname: Strasburger
authors.affiliation: Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Centre, P.O. Box 2040, 3000 CA Rotterdam, Netherlands.
authors.forename: Steven W
authors.initials: SW
authors.lastname: Lamberts
authors.affiliation: Princess Alexandra Hospital, 199 Ipswich Road, Brisbane, QLD 4102, Australia.
authors.forename: Ken K Y
authors.initials: KK
authors.lastname: Ho
authors.affiliation: Santiago de Compostela University and CIBERobn, Santiago de Compostela, E-15780, Spain.
authors.forename: Felipe F
authors.initials: FF
authors.lastname: Casanueva
authors.affiliation: Department of Medicine, Cedars-Sinai Medical Center, Room 2015, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.
authors.forename: Shlomo
authors.initials: S
authors.lastname: Melmed
mesh_terms: D000172:Acromegaly / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000401:mortality / Q000601:surgery; D032921:Consensus; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D010911:Pituitary Neoplasms / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I